These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23596182)

  • 1. The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity.
    Karczewska-Kupczewska M; Tarasów E; Nikolajuk A; Stefanowicz M; Matulewicz N; Otziomek E; Górska M; Straczkowski M; Kowalska I
    Diabetes Care; 2013 Sep; 36(9):2787-93. PubMed ID: 23596182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
    Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
    Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
    Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
    Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of MRS combined with DTI in evaluating brain development of infants aged from 2 months to 2 years old.
    Yang J; Sun H; Yang X; Jin B; Shen J; Hu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):910-919. PubMed ID: 36039588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal brain metabolite changes in preterm infants with normal development.
    Tanifuji S; Akasaka M; Kamei A; Araya N; Asami M; Matsumoto A; Sotodate G; Konishi Y; Shirasawa S; Toya Y; Kusano S; Chida S; Sasaki M; Matsuda T
    Brain Dev; 2017 Mar; 39(3):196-202. PubMed ID: 27838187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical alterations in anterior cingulate cortex in bipolar disorder: a proton magnetic resonance spectroscopy study (1H-MRS).
    Galińska-Skok B; Konarzewska B; Kubas B; Tarasów E; Szulc A
    Psychiatr Pol; 2016; 50(4):839-848. PubMed ID: 27847932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
    Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
    Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Yildiz-Yesiloglu A; Ankerst DP
    Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
    Simmons A; Smail M; Moore E; Williams SC
    Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organization of neurochemical interactions in young and older brains as revealed with a network approach: Evidence from proton magnetic resonance spectroscopy (
    Rodríguez-Nieto G; Levin O; Hermans L; Weerasekera A; Sava AC; Haghebaert A; Huybrechts A; Cuypers K; Mantini D; Himmelreich U; Swinnen SP
    Neuroimage; 2023 Feb; 266():119830. PubMed ID: 36566925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Metabolites on the Descending Limb of Acute Alcohol: A Preliminary 1H MRS Study.
    Monnig MA; Woods AJ; Walsh E; Martone CM; Blumenthal J; Monti PM; Cohen RA
    Alcohol Alcohol; 2019 Jan; 54(5):487-496. PubMed ID: 31322647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
    Szulc A; Konarzewska B; Galinska-Skok B; Lazarczyk J; Waszkiewicz N; Tarasow E; Milewski R; Walecki J
    Neurosci Lett; 2013 Jun; 547():37-41. PubMed ID: 23665527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
    Antuono PG; Jones JL; Wang Y; Li SJ
    Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy.
    Savic I; Thomas AM; Ke Y; Curran J; Fried I; Engel J
    Acta Neurol Scand; 2000 Sep; 102(3):179-88. PubMed ID: 10987378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.